首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1566199

果凍市場規模、佔有率、成長分析、按產品、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Biosurgery Market Size, Share, Growth Analysis, By Product (Bone-Graft Substitutes, Soft-Tissue Attachments), By Application (General Surgery, Gynecological Surgery), By End User (Hospitals, Clinics), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年果凍市場規模為145.6億美元，從2023年的155.6億美元成長到2031年的265.4億美元，預計複合年成長率為6.9%。

由於手術方法的進步和對微創手術的日益偏好，全球果凍市場正在經歷顯著成長。果凍包括使用止血劑、密封劑和軟組織修復產品等生物材料來幫助促進癒合過程並改善手術結果。有幾個因素促進了這個市場的擴張，包括手術數量的增加、慢性病盛行率的上升以及老年人口的增加。此外，個人化醫療的趨勢和創新生物製藥的市場開拓在加速市場成長方面發揮著重要作用。然而，市場面臨挑戰，因為嚴格的監管標準和與果凍產品相關的高成本可能會阻礙更廣泛的採用。儘管存在這些障礙，全球果凍市場為專注於創造和商業化先進外科技術的公司提供了巨大的商機。

市場概況
骨移植替代物
- 去礦物質骨基質
- 人工骨移植
- 骨形成蛋白
- 其他骨移植替代品
軟組織附著
- 合成網
- 生物網
- 同種異體移植
- 異種移植
止血劑
- 凝血酶止血劑
- 氧化再生纖維素止血劑
- 複方止血劑
手術密封劑和黏劑
- 天然/生物來源密封劑和黏劑
- 按類型
- 纖維蛋白基密封劑和黏劑
- 膠原蛋白密封劑和黏劑
- 明膠基密封劑和黏劑
- 白蛋白基密封劑
- 其他天然/生物來源密封劑和黏劑
- 按產地
- 動物性密封劑和黏劑
- 基於人血的密封劑和黏劑
- 合成和半合成密封劑和黏劑
- 基於 PEG 水凝膠的密封劑和黏劑
- 氰基丙烯酸酯密封劑和黏劑
- 胺甲酸乙酯密封劑和黏劑
- 其他合成和半合成密封劑和黏劑
防沾黏屏障
- 合成防黏材料
- 玻尿酸類防沾黏材料
- 再生纖維素系防沾黏材料
- 釘類防黏材料
- 其他合成防沾劑
- 天然防沾屏障
- 膠原蛋白和蛋白質黏附屏障
- 纖維蛋白基防沾黏材料
釘線加固

果凍市場：依應用分類

市場概況
整形外科手術
一般外科
神經外科
心血管外科
重組手術
婦科手術
泌尿系統
胸腔外科
其他用途

果凍市場：依最終用戶分類

市場概況
醫院
診所
其他最終用戶

果凍市場規模：按地區分類

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Baxter International Inc.（US）
B. Braun Melsungen AG（Germany）
Becton, Dickinson & Company（US）
Johnson & Johnson（US）
Medtronic Plc（Ireland）
Integra Lifesciences Holdings Corporation（US）
Commonwealth Serum Laboratories Limited（Australia）
Hemostasis LLC（US）
Pfizer Inc.（US）
Stryker Corporation（US）
Zimmer Biomet（US）
Kuros Biosciences AG（Switzerland）
Orthofix Medical Inc.（US）
Smith & Nephew Plc（UK）
Tissue Regenix Group Plc（UK）
Betatech Medical（Turkey）
Meril Life Sciences Pvt. Ltd.（India）
Samyang Holdings Corporation（South Korea）
Aroa Biosurgery Ltd.（New Zealand）
Meyer-Haake Gmbh（Germany）
Biom Up（France）
Biocer Entwicklungs-Gmbh（Germany）
Hannox International Corp.（Taiwan）

簡介目錄

Product Code: SQMIG35G2174

Biosurgery Market size was valued at USD 14.56 billion in 2022 and is poised to grow from USD 15.56 billion in 2023 to USD 26.54 billion by 2031, growing at a CAGR of 6.9% in the forecast period (2024-2031).

The global biosurgery market is undergoing notable growth, driven by advancements in surgical methods and the rising preference for minimally invasive procedures. Biosurgery encompasses the use of biological materials like hemostatic agents, sealants, and soft tissue repair products, which aid in enhancing the healing process and improving surgical results. Several factors are contributing to the expansion of this market, including the increasing number of surgeries, the rising incidence of chronic diseases, and the growing elderly population. Additionally, the trend toward personalized medicine and the development of innovative biologic products are playing a key role in accelerating market growth. However, the market faces challenges due to stringent regulatory standards and the high costs associated with biosurgery products, which may hinder wider adoption. Despite these obstacles, the global biosurgery market offers significant opportunities for companies focused on creating and commercializing advanced surgical technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biosurgery Market Segmental Analysis

Global Biosurgery Market is segmented by Product, Application, End User, end user and region. Based on Product, the market is segmented into Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants & Adhesives, Adhesion Barriers, Staple-Line and Reinforcement Agents. Based on Application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Urological Surgery, Thoracic Surgery, and Other Applications. Based on End User, the market is segmented into Hospitals, Clinics, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Biosurgery Market

A major factor fueling the growth of the global biosurgery market is the rising demand for minimally invasive surgical procedures. These products are commonly used in such surgeries due to their ability to reduce trauma, speed up recovery, and minimize scarring. As patients and surgeons increasingly favor less invasive techniques, the demand for biosurgery solutions continues to rise. Moreover, technological advancements, including the development of cutting-edge biomaterials and surgical sealants, are accelerating the market's expansion. These innovations are enhancing the effectiveness of biosurgery products, further boosting their adoption in various surgical applications.

Restraints in the Global Biosurgery Market

A significant challenge for the global biosurgery market is the strict regulatory requirements and prolonged approval processes for new products. Biosurgery products must undergo extensive testing, clinical trials, and meet stringent safety and efficacy standards. These regulatory demands can lead to delays in bringing new products to market and inflate development costs. Additionally, the complex regulatory environment can hinder manufacturers' ability to innovate and launch new offerings. The high costs of regulatory compliance and product development often create entry barriers, particularly for small and medium-sized companies, limiting their participation and slowing overall market growth.

Market Trends of the Global Biosurgery Market

A notable trend in the global biosurgery market is the increasing adoption of minimally invasive surgical procedures. These techniques provide multiple benefits compared to traditional open surgeries, such as smaller incisions, less scarring, quicker recovery, and fewer postoperative complications. Consequently, there is growing demand for biosurgical products tailored specifically for minimally invasive procedures. This trend is fueled by the rising preference among patients and healthcare providers for less invasive treatments that deliver comparable or improved outcomes. In response, manufacturers in the biosurgery market are focusing on developing innovative products and techniques to meet this demand and improve patient satisfaction.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Supply Chain Analysis

Biosurgery Market by Product

Market Overview
Bone-Graft Substitutes
- Demineralized Bone Matrix
- Synthetic Bone Grafts
- Bone Morphogenetic Proteins
- Other Bone-Graft Substitutes
Soft-Tissue Attachments
- Synthetic Meshes
- Biological Meshes
- Allografts
- Xenografts
Hemostatic Agents
- Thrombin-Based Hemostatic Agents
- Oxidized Regenerated Cellulose-Based Hemostatic Agents
- Combination Hemostatic Agents
Surgical Sealants & Adhesives
- Natural/Biological Sealants & Adhesives
- By Type
- Fibrin-Based Sealants & Adhesives
- Collagen-Based Sealants & Adhesives
- Gelatin-Based Sealants & Adhesives
- Albumin-Based Sealants
- Other Natural/Biological Sealants & Adhesives
- By Origin
- Animal-Based Sealants & Adhesives
- Human Blood-Based Sealants & Adhesives
- Synthetic And Semi-Synthetic Sealants & Adhesives
- PEG Hydrogel-Based Sealants & Adhesives
- Cyanoacrylate-Based Sealants & Adhesives
- Urethane-Based Sealants & Adhesives
- Other Synthetic And Semi-Synthetic Sealants & Adhesives
Adhesion Barriers
- Synthetic Adhesion Barriers
- Hyaluronic Acid-Based Adhesion Barriers
- Regenerated Cellulose-Based Adhesion Barriers
- Peg-Based Adhesion Barriers
- Other Synthetic Adhesion Barriers
- Natural Adhesion Barriers
- Collagen And Protein Adhesion Barriers
- Fibrin-Based Adhesion Barriers
Staple-Line Reinforcement Agents

Biosurgery Market by Application

Market Overview
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Other Applications

Biosurgery Market by End User

Market Overview
Hospitals
Clinics
Other End Users

Biosurgery Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Baxter International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson & Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra Lifesciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Commonwealth Serum Laboratories Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hemostasis LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kuros Biosciences AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissue Regenix Group Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Betatech Medical (Turkey)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Samyang Holdings Corporation (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aroa Biosurgery Ltd. (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meyer-Haake Gmbh (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biom Up (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocer Entwicklungs-Gmbh (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hannox International Corp. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments